What are the AHA/ACC guidelines on vasodilator therapy in the treatment of aortic regurgitation (AR)?

Updated: Nov 19, 2018
  • Author: Stanley S Wang, JD, MD, MPH; Chief Editor: Terrence X O'Brien, MD, MS, FACC  more...
  • Print

The current ACC/AHA guidelines provide the following recommendations for vasodilator therapy [4] :

  • Vasodilator therapy is indicated for long-term treatment in patients who have severe chronic AR and symptoms of LV dysfunction but who are not candidates for surgery.

  • Vasodilator therapy is reasonable for short-term therapy in patients with severe LV dysfunction and heart failure symptoms, in order to improve their hemodynamic profile before surgery

  • Vasodilator therapy is acceptable for long-term therapy in asymptomatic patients with severe AR and LV dilation with normal EF

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!